Life Edit Therapeutics is developing faster and safer gene editing therapeutics to cure genetic diseases. Current gene editing approaches have limited applicability and efficacy and cannot treat the most challenging genetic disorders. Life Edit is designing versatile editing options using their proprietary collection of non-pathogenic organisms to test novel RNA-guided nucleases and base editors. The goal is to develop innovative gene editors to target any genomic sequence to treat even the most challenging genetic disorders. With backing from ElevateBio and AgBiome, Life Edit is building a pipeline of in vivo gene therapies that enable editing with easier delivery and reduced immune response.